16 Osteogenesis Imperfecta Clinical Trials in Salt Lake City, UT (2026)

Q: Are there osteogenesis imperfecta clinical trials in Salt Lake City?

Yes, there are 16 osteogenesis imperfecta clinical trials currently recruiting in Salt Lake City, UT.

Q: How do I join a clinical trial in Salt Lake City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you.

Q: Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Osteogenesis Imperfecta Studies in Salt Lake City

NCT07224243Recruiting

Impact of Intraoperative Oxygenation Practices on Patient Outcomes

This multicenter, cluster-randomized, cluster-crossover clinical trial evaluates the impact of three intraoperative FiO2 (Fraction of Inspired Oxygen) oxygenation strategies-lower (FiO₂ 0.21-0.40), in...

Salt Lake City, UT54,000 participantsFrederic T Billings IV

View Study Details

NCT02848274Recruiting

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various ins...

Salt Lake City, UT2,000 participantsStanford University

View Study Details

NCT06032559Recruiting

Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment

This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigator...

Salt Lake City, UT450 participantsRutgers, The State University of New Jersey

View Study Details

NCT06223503Recruiting

VA Transitional Pain Service Study

The VA Community Care Program has provided an important resource to improve access to surgical care for Veterans unable to have treatment at VA Medical Centers (VAMC). However, there is an increased r...

Salt Lake City, UT400 participantsVA Office of Research and Development

View Study Details

NCT06494904Recruiting

Standard Versus High Dose ED-Initiated Buprenorphine Induction

This study is a multisite double-blind, double-dummy, randomized clinical trial enrolling ED patients with untreated moderate to severe opioid use disorder (OUD) to compare Standard Dose Induction (SD...

Salt Lake City, UT360 participantsYale University

View Study Details

NCT06651177Recruiting

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

The primary objective of this research study is to evaluate the effect of tirzepatide, relative to placebo, as an adjunct to BUP on retention, substance use, and sleep outcomes in individuals with OUD...

Salt Lake City, UT310 participantsT. John Winhusen, PhD

View Study Details

NCT03593759Recruiting

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active cli...

Salt Lake City, UT160 participantsOttawa Heart Institute Research Corporation

View Study Details

NCT07436793Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

This phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometri...

Salt Lake City, UT140 participantsNew Mexico Cancer Research Alliance

View Study Details

NCT05143840Recruiting

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). T...

Salt Lake City, UT100 participantsAugusta University

View Study Details

NCT06707493Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

This is a Phase 2 study of the study drug, ivosidenib (a mutant IDH1 inhibitor), compared to placebo, given to patients with IDH1-mutant acute myeloid leukemia (AML) after hematopoietic stem cell tran...

Salt Lake City, UT75 participantsMassachusetts General Hospital

View Study Details

NCT04892251Recruiting

Ketamine Assisted Psychotherapy for Opioid Use Disorder

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder....

Salt Lake City, UT60 participantsUniversity of Utah

View Study Details

NCT04838041Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have...

Salt Lake City, UT51 participantsMedical College of Wisconsin

View Study Details

NCT05145816Recruiting

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

The goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and amyloidosis, and to determine the most effective dose o...

Salt Lake City, UT37 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT04925479Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

The aim of this study is to support development of asciminib in the pediatric population (1 to \<18 years) previously treated with one or more TKIs. Full extrapolation of the efficacy of asciminib fro...

Salt Lake City, UT34 participantsNovartis Pharmaceuticals

View Study Details

NCT05101551Recruiting

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

This is a Phase 1, open label, multicenter, dose finding study with dose expansion intended to evaluate the safety and tolerability of talazoparib in combination with conventional chemotherapy. Prelim...

Salt Lake City, UT34 participantsNorman J. Lacayo

View Study Details

NCT03953768Recruiting

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

Vagal nerve stimulation is a neurosurgical procedure consisting of implantation of an impulse generator battery with leads placed into the vagus nerve in the neck. This procedure was FDA approved for ...

Salt Lake City, UT30 participantsUniversity of Louisville

View Study Details

About Osteogenesis Imperfecta Clinical Trials in Salt Lake City

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 16 osteogenesis imperfecta clinical trials recruiting participants in Salt Lake City, UT. These studies are seeking a combined 58,241 participants. Research is being sponsored by Frederic T Billings IV, Stanford University, Rutgers, The State University of New Jersey and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Salt Lake City — FAQ

Are there osteogenesis imperfecta clinical trials in Salt Lake City?

Yes, there are 16 osteogenesis imperfecta clinical trials currently recruiting in Salt Lake City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Salt Lake City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salt Lake City research site will contact you about next steps.

Are clinical trials in Salt Lake City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salt Lake City studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 16 active trials in Salt Lake City are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 13, 2026 from ClinicalTrials.gov